imipramine has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodnanova, M; Cibulka, M; Evinova, A; Hatokova, Z; Racay, P | 1 |
| Anagnostopoulou, A; Aschenbach, JR; Kolisek, M; Montezano, AC; Sponder, G; Touyz, RM; Vormann, J | 1 |
2 other study(ies) available for imipramine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Differential impact of imipramine on thapsigargin- and tunicamycin-induced endoplasmic reticulum stress and mitochondrial dysfunction in neuroblastoma SH-SY5Y cells.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Endoribonucleases; Humans; Imipramine; Mitochondria; Neuroblastoma; Neurodegenerative Diseases; Protein Serine-Threonine Kinases; RNA Splicing; Signal Transduction; Thapsigargin; Tunicamycin; Ubiquitin-Protein Ligases; X-Box Binding Protein 1 | 2021 |
PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases.
Topics: Animals; Cardiovascular Diseases; Cation Transport Proteins; Chronic Disease; Humans; Imipramine; Intracellular Signaling Peptides and Proteins; Magnesium Deficiency; Metabolic Diseases; Molecular Targeted Therapy; Neurodegenerative Diseases; Oncogene Proteins; Oxidative Stress; Protein Deglycase DJ-1; Receptors, Androgen; Risk Factors; Signal Transduction; Up-Regulation | 2015 |